by In2Pharma | May 22, 2025 | News
Belgium In 2023, a new royal decree (19 January 2023) was issued by the Belgian government allowing the export (every shipment to another country) of medicines to be temporarily restricted. The importance of complying with the decree has been made very clear as this...
by In2Pharma | May 22, 2025 | News
Belgium The FAMHP launched a new version of Narcoreg, the mandatory online application for the registration of deliveries and receipts of narcotics and psychotropic substances, on 21 May 2025. The new version was developed based on valuable feedback from the industry...
by In2Pharma | Apr 11, 2025 | News
Luxembourg All Marketing Authorization Holders (MAHs) should have received a communication from the Luxembourg authorities regarding discrepancies in Marketing Authorization (MA) numbers for MRP/DCP and national procedure products in XEVMPD. This is part of an ongoing...
by In2Pharma | Apr 4, 2025 | News
The Netherlands Keuringsraad KOAGKAG can be consulted for advice with regard to promotional material and claims taking into account the current codes and guidelines for medicinal products, medical devices and health products. As the complexity of the questions...
by In2Pharma | Apr 4, 2025 | News
Europe In December 2024, a draft version of an amendment to the European legislation for pharmacovigilance activities (Implementing Regulation EU No. 520/2012) has been published by the European Commission. Public feedback was collected until the 15th of January 2025....
